GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Pre-Tax Income

Acticor Biotech (XPAR:ALACT) Pre-Tax Income : €-18.65 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Acticor Biotech's pretax income for the six months ended in Jun. 2023 was €-10.08 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was €-18.65 Mil. Acticor Biotech's pretax margin was %.

During the past 6 years, Acticor Biotech's highest Pretax Margin was -11978.00%. The lowest was -11978.00%. And the median was -11978.00%.


Acticor Biotech Pre-Tax Income Historical Data

The historical data trend for Acticor Biotech's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Pre-Tax Income Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pre-Tax Income
Get a 7-Day Free Trial -5.99 -5.25 -7.65 -12.61 -15.88

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only -5.91 -6.70 -7.31 -8.57 -10.08

Competitive Comparison of Acticor Biotech's Pre-Tax Income

For the Biotechnology subindustry, Acticor Biotech's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acticor Biotech's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acticor Biotech's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Acticor Biotech's Pre-Tax Income falls into.



Acticor Biotech Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Acticor Biotech's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-15.102+0+-0.766+0.008+-0.017999999999999
=-15.88

Acticor Biotech's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-8.81+0+-1.734+0.474+-0.010999999999999
=-10.08

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-18.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acticor Biotech  (XPAR:ALACT) Pre-Tax Income Explanation

Acticor Biotech's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-10.081/0
=%

During the past 6 years, Acticor Biotech's highest Pretax Margin was -11978.00%. The lowest was -11978.00%. And the median was -11978.00%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acticor Biotech Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Acticor Biotech (XPAR:ALACT) Business Description

Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines